In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Yamanouchi buys Fujisawa for $7.64bn

Executive Summary

Yamanouchi Pharmaceutical has agreed to acquire Fujisawa Pharmaceutical in a stock swap valued at $7.64bn (Y827.54bn). The merger will create the largest pharmaceutical company in Japan--17th on the world pharma stage--with combined sales of approximately Y800bn.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies

Advertisement
UsernamePublicRestriction

Register